FSGEX
Price
$14.15
Change
-$0.01 (-0.07%)
Updated
Dec 20 closing price
IYITX
Price
$20.45
Change
-$0.04 (-0.20%)
Updated
Dec 20 closing price
Ad is loading...

FSGEX vs IYITX

Header iconFSGEX vs IYITX Comparison
Open Charts FSGEX vs IYITXBanner chart's image
Fidelity Series Global ex US Index
Price$14.15
Change-$0.01 (-0.07%)
VolumeN/A
CapitalizationN/A
Delaware Ivy International Core Eq R
Price$20.45
Change-$0.04 (-0.20%)
VolumeN/A
CapitalizationN/A
FSGEX vs IYITX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSGEX vs. IYITX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSGEX is a Buy and IYITX is a Hold.

FUNDAMENTALS
Fundamentals
FSGEX has more cash in the bank: 49.3B vs. IYITX (1.44B). FSGEX pays higher dividends than IYITX: FSGEX (2.77) vs IYITX (2.15). FSGEX was incepted earlier than IYITX: FSGEX (15 years) vs IYITX (12 years). IYITX is a more actively managed with annual turnover of: 43.00 vs. FSGEX (6.00). FSGEX (0) and IYITX (0) have matching initial minimum investment requirements. FSGEX annual gain was more profitable for investors over the last year : 6.66 vs. IYITX (4.52). IYITX (23.92) and FSGEX (22.81) have equivalent 5 years return.
FSGEXIYITXFSGEX / IYITX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence15 years12 years-
Gain YTD5.1173.522145%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets49.3B1.44B3,416%
Annual Yield % from dividends2.772.15129%
Returns for 1 year6.664.52147%
Returns for 3 years4.504.36103%
Returns for 5 years22.8123.9295%
Returns for 10 years49.7530.62162%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UNTY43.921.03
+2.40%
Unity Bancorp
MATX136.890.16
+0.12%
Matsons
ORLA5.57-0.03
-0.54%
Orla Mining Ltd
IMO61.73-0.78
-1.25%
Imperial Oil Limited
ELEV0.58-0.05
-7.30%
Elevation Oncology